by The global virus filtration market size was valued at USD 5.45 billion in 2024 and is expected to hit around USD 19.17 billion by 2034, growing at a CAGR of 13.40% from 2025 to 2034.
Get a Sample@https://www.visionresearchreports.com/report/sample/41685
Virus Filtration Market Overview
The virus filtration market is undergoing robust expansion as biopharmaceutical production, vaccine development, and cell therapy manufacturing continue to grow globally. Virus filtration plays a critical role in ensuring the safety of biological products by removing viral contaminants from biologics, vaccines, and plasma-derived therapeutics. As demand for virus-safe drugs and stringent regulatory guidelines increase, virus filtration has become a vital component across the bioprocessing workflow.
Virus Filtration Market Growth
Pharmaceutical and biotech companies are ramping up production capabilities with a focus on advanced filtration systems that comply with FDA and EMA standards. Additionally, the increasing adoption of monoclonal antibodies (mAbs), recombinant proteins, and gene therapies further drives the need for efficient and validated virus filtration technologies, boosting market growth.
Virus Filtration Market Dynamics
Driver
Burgeoning Biotech Sector
Biotechnology is a rapidly expanding sector that uses living organisms to make products to potentially improve health. The growing demand for enhanced health outcomes leads to an increasing number of biotech startups. The rising investments in biotech research and startups are a major driver in burgeoning the biotech sector. According to the McKinsey & Company report, the total biotech IPO funding raised in the first three quarters of 2023 was around $3.4 billion. Similarly, venture capitalists’ investments in startups accounted for $12 billion. While the startups secured more than $22 billion in funding across early- and late-stage rounds. These investments and technological advancements lead to novel innovations in products.
Restraint
High Cost and Virus Filter Overloading
The major challenge of the virus filtration market is the high cost of virus filtration. The cost of virus filtration varies depending on the system’s size, flow rate, and materials used. The average cost ranges from $8,000 to $100,000, limiting the affordability of many companies in LMICs. Another major challenge is the virus filter overloading.
Opportunity
Novel Advancements
Technological advancements favor novel advancements and innovations in virus filtration. Virus filtration is an essential component of the downstream purification processing of antibodies and other biotherapeutics. The growing demand for high-concentration formulations, intensified unit operations, connected and continuous processing, and the implementation of single-use technologies increase the need for virus filters. Hence, manufacturers design and produce novel virus filters to fulfill these demands. New technologies are implemented in filter manufacturing to improve virus removal capability, process robustness, and integrity testing sensitivity. Several researchers are investigating novel filter membrane construction materials to improve efficiency.
How Can AI Improve the Virus Filtration Market?
Artificial intelligence (AI) and machine learning (ML) have become integral parts of the pharmaceutical and biotechnology manufacturing processes. AI can detect the presence of viruses during the manufacturing of biologicals, helping manufacturers to take preventive measures. AI introduces automation in processes that are essential to the product safety profile, such as virus filtration. Fully automated solutions improve batch compliance, streamline processing, and lower the possibility of operator error. AI can also optimize virus filtration by analyzing vast datasets from process runs. Additionally, AI can automate the design and manufacturing of virus filters depending on the requirements. Sensors can help to obtain real-time information about the presence and amount of viruses present in the product.
Virus Filtration Market Trends
- In June 2023, 3M announced its plan to invest $146 million to expand its biopharma filtration capabilities at manufacturing facilities in Europe. The investment will accelerate its development and delivery of viral filtration equipment for bioprocessing, biological, and small molecule pharmaceutical manufacturing applications.
- In March 2023, TeraPore Technologies announced that it had raised $10 million to launch its IsoBlock virus filter and expand the use of its core technology into new high-value markets.
Read More:https://www.heathcareinsights.com/remote-work-security-market/
Top Companies in Virus Filtration Market
- Merck KGaA (MilliporeSigma)
- Sartorius AG
- GE Healthcare (now part of Cytiva)
- Pall Corporation (a division of Danaher Corporation)
- 3M Company
- Danaher Corporation
- Thermo Fisher Scientific Inc.
- Asahi Kasei Corporation
- Porvair Filtration Group
- Parker Hannifin Corporation
Virus Filtration Market Segmentation
- By Product Type: Filters, Kits & Reagents, Services
- By Technology: Membrane Filtration, Chromatography, Others
- By Application: Biologicals, Vaccines & Therapeutics, Blood & Blood Products, Medical Devices
- By End-User: Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs), Academic Research Institutes
Future Outlook
The future of the virus filtration market is poised for sustained growth, propelled by innovations in filtration technologies and increasing investment in biomanufacturing infrastructure. As precision medicine, personalized therapies, and biosimilars gain momentum, virus filtration will continue to be indispensable for ensuring product purity and regulatory compliance. The market is likely to witness strategic collaborations, technology upgrades, and regional capacity-building as stakeholders work to meet global therapeutic demands.
Buy this Premium Research Report@https://www.heathcareinsights.com/wp-admin/post-new.php
You can place an order or ask any questions, please feel free to contact
sales@visionresearchreports.com| +1 650-460-3308
